Neurogene Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Neurogene Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q3 2024.
  • Neurogene Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 17M shares, a 3699% increase year-over-year.
  • Neurogene Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 55.2M shares, a 0.33% increase from 2021.
  • Neurogene Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 55M shares, a 6.21% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 17M +16.5M +3699% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 16.9M +16.5M +3712% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 16.9M -38.5M -69.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 492K -54.7M -99.1% Dec 19, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 446K -10.6M -96% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 444K -54.8M -99.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 55.4M +277K +0.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 55.2M +179K +0.33% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-20
Q3 2022 11.1M -44M -79.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 55.2M +177K +0.32% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 55.1M +199K +0.36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 55M +3.22M +6.21% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 55.1M +966K +1.79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 55M +5.63M +11.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 54.9M +5.78M +11.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 51.8M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 54.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 49.4M +25.9M +110% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 49.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q2 2019 23.5M +15.6K +0.07% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-01
Q2 2018 23.5M +77.6K +0.33% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q2 2017 23.4M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2014 3.15M +2.85M +943% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q1 2013 302K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.